StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Net Debt by Year

Net Debt ($M)

Novartis Net Debt: $21,947M in FY2025, up 36.0% from a year earlier.

Latest, FY2025
21,947
Period ended Dec 31, 2025
Change on a year earlier
+36.0%
16,141 in FY2024
History
6 years
Since FY2020
Sources
6
Documents cited below

Where the FY2025 figure comes from

“|| Net debt at end of period | – 37 374 | – 21 947 | – 20 365”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Displays the absolute value of financial debt less cash, cash equivalents, marketable securities, and derivatives.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNet Debt ($M)Year on yearSource
FY2025Dec 31, 202521,947+36.0%Novartis Form 6-K (0001114448-26-000014) ↗
FY2024Dec 31, 202416,141+58.5%Novartis Form 6-K (0001114448-25-000003) ↗
FY2023Dec 31, 202310,183+40.6%Novartis Form 6-K (0001370368-24-000022) ↗
FY2022Dec 31, 20227,245+734.7%Novartis Form 6-K (0001370368-23-000068) ↗
FY2021Dec 31, 2021868-96.5%Novartis Form 6-K (0001370368-22-000077) ↗
FY2020Dec 31, 202024,481–Novartis Form 6-K (0001370368-21-000072) ↗

Breakdown

What makes up net Debt

Cite this data

StockData. (2026). Novartis Net Debt ($M), annual FY2020–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/nd-net-debt

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.